Molina Healthcare

MOH · NYSE · Health Care · Financials, fiscal 2016 to 2025

MOH · Last close · October 26, 2026

$204.79

Molina Healthcare's revenue rose 11.8% to $45.4 billion in fiscal 2025. Its operating margin was 1.7%, down from 4.2% a year earlier. Free cash flow was −$636 million, against $544 million a year earlier. It paid out $1.0 billion in dividends and buybacks. The diluted share count fell 8.3%.

MOLINA HEALTHCARE, INC. Latest fiscal year ended December 31, 2025 10-K filed February 10, 2026 · 0001179929-26-000005 Updated October 22, 2026

Revenue

$45.4B

11.8%

Operating margin

1.7%

2.5 pts

Net income

$472M

60.0%

Free cash flow

−$636M

$544M a year earlier

Return on equity

11.0%

16.1 pts

Market cap

$10.5B

Oct 26 close

P/E

—

Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

About these figures. Health insurers don't report a gross profit: their main cost is medical claims, which the SEC's structured data doesn't count as cost of revenue, so gross profit and gross margin are left blank.

Charts show fiscal years, from the 10-K filings.

Revenue and margins

Revenue

US$ billions, fiscal years

Margins

Percent of revenue

GrossOperatingNetFree cash flow

Net income and earnings per share

From fiscal 2016 to 2025, earnings per share grew 28.7% a year and net income 27.8% a year, as buybacks cut the share count by 6%.

Net income

US$ billions, fiscal years; loss years in red.

Diluted earnings per share

US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity

Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.

Return on capitalReturn on equity

Cash flow

Free cash flow

US$ billions. Cash from operations minus capital expenditure; negative years in red.

Payouts and share count

Dividends and buybacks

US$ billions, cash paid in each fiscal year

DividendsShare buybacks

Diluted share count

Weighted-average diluted shares, millions

Valuation

Two ways to value Molina Healthcare yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.

What Molina Healthcare says to expect

Full year 2026: premium revenuePremium revenue guidance for the full year is unchanged at approximately $42 billion.
Full year 2026: earnings per shareThe Company expects its full year 2026 GAAP earnings to be at least $2.38 per diluted share and reaffirmed its full year 2026 adjusted earnings of at least $5.25 per diluted share.

The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed October 21, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Discounted cash flow (DCF)

A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Molina Healthcare's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.

Value per share on three example scenarios, from Molina Healthcare's 3-year average free cash flow of $495M, net cash of $4.3B at December 31, 2025 and 53 million diluted shares, from its filings. The scenarios are fitted to Molina Healthcare: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 12.4% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 7% for a stable business (Managed Health Care); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

From the filings

Starting free cash flow, US$ millions

The average of fiscal 2023 to 2025.

Net cash, US$ millions

Cash and short-term investments minus debt and finance leases at December 31, 2025. Negative means net debt.

Diluted shares, millions

Weighted-average diluted shares in fiscal 2025.

Your assumptions

Start from

Fitted to Molina Healthcare's own revenue growth, as above. Cautious: growth of 6% then 4% a year, 2% after year 10, a 8% discount rate. Base: growth of 12.5% then 7.5% a year, 2.5% after year 10, a 7% discount rate. Optimistic: growth of 18.5% then 11% a year, 3% after year 10, a 6% discount rate.

Free cash flow growth, years 1 to 5 (% a year)

Free cash flow growth, years 6 to 10 (% a year)

Growth after year 10 (% a year)Long-run growth forever after year 10. Usually close to inflation, and always below the discount rate.

Discount rate (% a year)The yearly return an investor wants for the risk. A higher rate gives a lower value.

Value per share on these assumptions

—

Last close, October 26, 2026: $204.79
Value on these assumptions, against the last close: —

Cash flows in years 1 to 10, valued today: —
Everything after year 10, valued today: —
Plus net cash: —
Share of value from after year 10: —

Projected free cash flow

US$ billions. Each column is one year's projected free cash flow, split into what it is worth today and the part removed by discounting.

Value todayRemoved by discounting

How the value changes with two assumptions

Value per share in US$, with the growth rates above. The highlighted cell matches the current assumptions.

How the model works. Free cash flow grows at the first rate for five years and the second rate for five more, and each year is discounted at the discount rate. Everything after year 10 is valued as year-10 cash flow × (1 + growth after year 10) ÷ (discount rate − growth after year 10), discounted back ten years. Net cash is added and the total is divided by diluted shares. The result depends entirely on the assumptions. It is not a forecast, a price target or a recommendation. The last close is the consolidated US closing price, from Databento.

Price-to-earnings (P/E) method

Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.

The P/E method needs positive earnings, and Molina Healthcare's latest diluted earnings per share were negative or zero.

Balance sheet

Fiscal year end	FY21	FY22	FY23	FY24	FY25
Cash and short-term investments	7.6	7.5	9.1	9.0	8.3
Debt incl. finance leases	2.4	2.4	2.4	3.1	4.0
Net debt (negative means net cash)	−5.2	−5.1	−6.7	−5.8	−4.3
Net debt to EBITDA	−4.5x	−3.8x	−3.8x	−3.1x	−4.4x
Debt to equity	0.9x	0.8x	0.6x	0.7x	1.0x
Interest coverage	8.5x	10.7x	14.4x	14.5x	4.1x
Current ratio	1.4x	1.5x	1.5x	1.6x	1.7x
Quick ratio	1.4x	1.5x	1.5x	1.6x	1.7x

US$ billions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Insider trades

Over the 12 months between October 27, 2025 and October 26, 2026, 1 insider bought $100,128 of Molina Healthcare shares on the open market, and 4 insiders sold $3.6 million.

Date	Insider	Trade	Shares	Price	Value	Filing
May 14, 2026	Maurice HebertChief Accounting Officer	Sold	600	$191.55	$114,930	Form 4
May 11, 2026	Jeff D. BarlowChief Legal Officer	Sold	17,811	$186.12	$3.3 million	Form 4
Mar 12, 2026	Ronna RomneyDirector	Sold	506	$146.92	$74,342	Form 4
Feb 11, 2026	Richard C ZoreticDirector	Bought	800	$125.16	$100,128	Form 4
Nov 24, 2025	Richard M SchapiroDirector	Sold	357	$143.02	$51,058	Form 4

Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Piotroski F-score

The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.

Test	FY23	FY24	FY25
Net income is positive	Pass	Pass	Pass
Cash from operations is positive	Pass	Pass	Fail
Return on assets rose	Pass	Fail	Fail
Cash from operations exceeds net income	Pass	Fail	Fail
Debt fell relative to assets	Pass	Fail	Fail
Current ratio rose	Pass	Pass	Pass
Share count didn't rise	Pass	Pass	Pass
Gross margin rose	—	—	—
Revenue rose relative to assets	Pass	Fail	Pass
F-score	8 of 8	4 of 8	4 of 8
Accruals ratio	−4.2%	3.5%	6.5%

The accruals ratio is net income minus cash from operations, over average total assets.

Compare

Put Molina Healthcare side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

Company	Year	Revenue growth	Operating margin	Free cash flow margin	Return on capital	Net debt to EBITDA	F-score	Compare
Molina Healthcare	FY25	11.8%	1.7%	−1.4%	—	−4.4x	4
Humana	FY25	10.1%	2.1%	0.3%	25.7%	−2.2x	5	Compare
Oscar Health	FY25	27.5%	−3.4%	9.1%	—	—	4	Compare
Centene	FY25	19.4%	−3.9%	2.2%	−26.4%	—	5	Compare
Elevance Health	FY25	12.5%	3.6%	1.6%	15.2%	−0.4x	6	Compare

Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score above.

10 years of figures

Fiscal year	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Income statement
Revenue	17.8	19.9	18.9	16.8	19.4	27.8	32.0	34.1	40.6	45.4
Revenue growth	25.4%	11.8%	−5.0%	−10.9%	15.4%	43.0%	15.1%	6.6%	19.3%	11.8%
Gross profit	—	—	—	—	—	—	—	—	—	—
Research and development	—	—	—	—	—	—	—	—	—	—
Operating income	0.3	−0.6	1.1	1.0	1.1	1.0	1.2	1.6	1.7	0.8
Net income	0.1	−0.5	0.7	0.7	0.7	0.7	0.8	1.1	1.2	0.5
Diluted EPS (US$)	0.92	−9.07	10.61	11.47	11.23	11.25	13.55	18.77	20.42	8.92
Diluted shares (millions)	56	56	67	64	60	59	58	58	58	53
Cash flow
Cash from operations	0.7	0.8	−0.3	0.4	1.9	2.1	0.8	1.7	0.6	−0.5
Capital expenditure	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Free cash flow	0.5	0.7	−0.3	0.4	1.8	2.0	0.7	1.6	0.5	−0.6
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Share buybacks	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.0	1.0	1.0
Acquisitions	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.3	0.2
Stock-based compensation	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0
Balance sheet at fiscal year end
Cash and short-term investments	4.6	5.7	4.5	4.4	6.0	7.6	7.5	9.1	9.0	8.3
Debt incl. finance leases	1.4	2.2	1.5	1.5	2.4	2.4	2.4	2.4	3.1	4.0
Total assets	7.4	8.5	7.2	6.8	9.5	12.2	12.3	14.9	15.6	15.6
Total liabilities	5.8	7.1	5.5	4.8	7.4	9.6	9.3	10.7	11.1	11.5
Shareholders' equity	1.6	1.3	1.6	2.0	2.1	2.6	3.0	4.2	4.5	4.1
Margins and ratios
Gross margin	—	—	—	—	—	—	—	—	—	—
Operating margin	1.7%	−2.8%	6.0%	6.2%	5.5%	3.7%	3.7%	4.6%	4.2%	1.7%
Net margin	0.3%	−2.6%	3.7%	4.4%	3.5%	2.4%	2.5%	3.2%	2.9%	1.0%
Free cash flow margin	2.8%	3.6%	−1.8%	2.2%	9.4%	7.3%	2.1%	4.6%	1.3%	−1.4%
Return on capital	—	—	—	—	—	—	—	—	—	—
Return on equity	3.2%	−34.3%	47.4%	40.9%	33.2%	27.9%	28.3%	30.4%	27.1%	11.0%
Return on assets	0.7%	−6.4%	9.1%	10.6%	8.2%	6.1%	6.5%	8.0%	7.7%	3.0%
Net debt to EBITDA	−6.4x	—	−2.4x	−2.6x	−3.1x	−4.5x	−3.8x	−3.8x	−3.1x	−4.4x

US$ billions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)

Source: Molina Healthcare's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Molina Healthcare.